Continuously updated synthesis method about 56621-48-8

When you point to this article, it is believed that you are also very interested in this compound(56621-48-8)Name: 4-(Piperazin-1-yl)phenol and due to space limitations, I can only present the most important information.

The preparation of ester heterocycles mostly uses heteroatoms as nucleophilic sites, which are achieved by intramolecular substitution or addition reactions. Compound: 4-(Piperazin-1-yl)phenol( cas:56621-48-8 ) is researched.Name: 4-(Piperazin-1-yl)phenol.Jin, Zhen; Wang, Le; Gao, Hong; Zhou, Ying-Hui; Liu, Ya-Hong; Tang, You-Zhi published the article 《Design, synthesis and biological evaluation of novel pleuromutilin derivatives possessing acetamine phenyl linker》 about this compound( cas:56621-48-8 ) in European Journal of Medicinal Chemistry. Keywords: acetamine phenyl pleuromutilin preparation antibacterial pharmacokinetic; Antibiotics; In vivo; MRSA; Pleuromutilin; Synthesis. Let’s learn more about this compound (cas:56621-48-8).

A series of novel acetamine Ph pleuromutilin derivatives incorporating 2-aminothiophenol moieties into the C14 side chain were synthesized via acylation reactions under mild conditions. The in vitro antibacterial activities of the synthesized derivatives against three Staphylococcus aureus (MRSA ATCC 43300, ATCC 29213 and AD 3) and two Escherichia coli (ATCC 25922 and 9-1) were evaluated by the broth dilution method. Most of the synthesized derivatives displayed potent activities. Compound I was found to be the most active antibacterial derivative against MRSA (minimal inhibitory concentration = 0.015 μg/mL) which may lead to a promising antibacterial drug. Furthermore, compound I displayed more rapid bactericidal kinetic than tiamulin in in vitro time-kill studies and possessed a longer PAE than tiamulin against MRSA. The PK properties of compound I were then measured. The half life (t1/2), clearance rate (Cl) and the area under the plasma concentration-time curve (AUC0→∞) of compound I were 6.88 h, 21.64 L/h/kg and 0.48 μg h/mL, resp. The in vivo antibacterial activities of compound I against MRSA were further evaluated using thigh infection model and systemic infection model. Compound I possessed superior antibacterial efficacy to tiamulin against MRSA infection in both model.

When you point to this article, it is believed that you are also very interested in this compound(56621-48-8)Name: 4-(Piperazin-1-yl)phenol and due to space limitations, I can only present the most important information.

Reference:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem